Qatar vs Sri Lanka: HIV-positive TB patients on ART (antiretroviral therapy)
Qatar
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Qatar rank
1st
Sri Lanka rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Qatar
- Sri Lanka
How they compare
Qatar currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 4 times across 9 shared years of data; in 2007 it was Sri Lanka ahead.
Qatar ranks 1st and Sri Lanka ranks 1st of 144 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Qatar | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 81.7% | 18.3% | Qatar |
| 2020s | 100.0% | 67.0% | 33.0% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Qatar or Sri Lanka?
- Qatar, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Qatar and Sri Lanka?
- 0.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and Sri Lanka?
- 9 years are reported by both, from 2007 to 2024.
- How do Qatar and Sri Lanka rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Qatar ranks 1st and Sri Lanka ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.